Drug · DIN 00329320
SANDOMIGRAN
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since July 28, 2021; first marketed January 1, 1975.
- Drug Identification Number (DIN)
- 00329320
- Company (DIN owner)
- Paladin Pharma Inc.Montreal, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Pizotifen N02CX01
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| PIZOTIFEN (PIZOTIFEN MALATE) | 0.50 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 24, 2009: NOC 10289New Drug Submission (NDS) · Manufacturer name change
- February 8, 2007: NOC 8578New Drug Submission (NDS) · Manufacturer name change
- October 28, 2004: NOC 5723New Drug Submission (NDS) · Manufacturer name change
- November 4, 2002: NOC 739New Drug Submission (NDS) · Manufacturer name change